A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate.
about
The role of pentosan polysulfate in treatment approaches for interstitial cystitisPharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review.Current guidelines in the management of interstitial cystitisInterstitial cystitis/bladder pain syndrome and glycosaminoglycans replacement therapyThe enigma of men with interstitial cystitis/bladder pain syndromeOral glucosamine and the management of feline idiopathic cystitisUrinary bladder, cystitis and nerve/urothelial interactions.Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis.Interstitial cystitis. Etiology, diagnosis, and treatment.Interstitial cystitis and endometriosis in patients with chronic pelvic pain: The "Evil Twins" syndrome.Interstitial cystitis in persistent posthysterectomy chronic pelvic painLong-term efficacy and tolerability of pentosan polysulphate sodium in the treatment of bladder pain syndrome.Interstitial cystitis and pelvic floor dysfunction: a comprehensive review.Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study.Recent advances in intravesical drug/gene deliveryMolecular size affects urine excretion of pentosan polysulfateCUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome.Therapeutic Potential of Human Chorionic Gonadotropin Against Painful Bladder Syndrome/Interstitial Cystitis.Urothelial cytoprotective activity of Tamm-Horsfall protein isolated from the urine of healthy subjects and patients with interstitial cystitis.The combination therapy of prednisolone and tacrolimus for severe painful bladder syndrome/interstitial cystitisMirabegron as adjuvant treatment for patients with interstitial cystitis/bladder pain syndrome.Efficacy of intravesical pentosan polysulfate sodium in cats with obstructive feline idiopathic cystitis.
P2860
Q24548035-A370DDCA-166C-4B99-989C-6C9ABBE8EEF8Q24681154-9DE39D38-38B4-47F1-8DC8-6EA526164B0DQ26773527-F140B3BC-0D00-4FFA-90A0-B69054925FB8Q26773545-5183BF17-3289-47FF-81C2-3A4CA4B46980Q26774274-1E629102-7163-486F-AE99-5FBC1331001DQ28273057-4934BBB2-B897-4428-BB79-B10FEB0471B0Q30412893-AB421FC0-226F-4B91-9538-F9ED84C2C0DAQ33870858-218D3DED-3785-4EB3-B378-EBAC0A15D7D7Q34128252-DD7039BD-3B90-49E1-96D2-2B384D02B98FQ34464668-1A97B29A-C558-487A-A1A8-AE84D630E319Q34470262-B6BE94F9-EA3F-44D7-BFBE-3D3F1771252AQ35014749-4242868C-905B-4D51-AA70-741A087A6FCEQ35753020-FB6CE51A-E577-4F13-96D4-4BF75F075FCEQ36241186-F1CF2995-51D9-4517-B219-542EB55D83BFQ36556653-B7484E47-F07B-4D90-B398-B3119450DF51Q36639368-06DC73CB-020E-4CFC-AD79-39AC0C08527CQ37341605-E53058A7-8EDD-4205-9046-01DF705EBCA6Q38785364-B060C9CA-4257-4638-B6CD-191EA79234B9Q40877001-B71B1655-DF13-471E-8B0B-609D78D4179CQ42151852-2D0D5880-3515-4F06-BB47-BB67621E3E44Q47240358-AA826AA6-4839-4AA5-85FF-E95E2B0F79DCQ53451747-C4EF20DA-3100-45CF-B5CA-6175991D1B6B
P2860
A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
A quantitatively controlled me ...... ficacy of pentosanpolysulfate.
@en
A quantitatively controlled me ...... ficacy of pentosanpolysulfate.
@nl
type
label
A quantitatively controlled me ...... ficacy of pentosanpolysulfate.
@en
A quantitatively controlled me ...... ficacy of pentosanpolysulfate.
@nl
prefLabel
A quantitatively controlled me ...... ficacy of pentosanpolysulfate.
@en
A quantitatively controlled me ...... ficacy of pentosanpolysulfate.
@nl
P2093
P1476
A quantitatively controlled me ...... ficacy of pentosanpolysulfate.
@en
P2093
P304
P356
10.1016/S0022-5347(17)35629-X
P407
P577
1993-09-01T00:00:00Z